[1]
Mao AS, Mooney DJ. Regenerative medicine: Current therapies and future directions. Proceedings of the National Academy of Sciences of the United States of America. 2015 Nov 24:112(47):14452-9. doi: 10.1073/pnas.1508520112. Epub
[PubMed PMID: 26598661]
Level 3 (low-level) evidence
[2]
Henrotin Y, Raman R, Richette P, Bard H, Jerosch J, Conrozier T, Chevalier X, Migliore A. Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. Seminars in arthritis and rheumatism. 2015 Oct:45(2):140-9. doi: 10.1016/j.semarthrit.2015.04.011. Epub 2015 Apr 30
[PubMed PMID: 26094903]
Level 3 (low-level) evidence
[3]
Balazs EA, Denlinger JL. Viscosupplementation: a new concept in the treatment of osteoarthritis. The Journal of rheumatology. Supplement. 1993 Aug:39():3-9
[PubMed PMID: 8410881]
[4]
Dagenais S, Yelland MJ, Del Mar C, Schoene ML. Prolotherapy injections for chronic low-back pain. The Cochrane database of systematic reviews. 2007 Apr 18:2007(2):CD004059
[PubMed PMID: 17443537]
Level 1 (high-level) evidence
[5]
Siadat AH, Isseroff RR. Prolotherapy: Potential for the Treatment of Chronic Wounds? Advances in wound care. 2019 Apr 1:8(4):160-167. doi: 10.1089/wound.2018.0866. Epub 2019 Apr 3
[PubMed PMID: 31646060]
Level 3 (low-level) evidence
[6]
Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain. Clinical medicine insights. Arthritis and musculoskeletal disorders. 2016:9():139-59. doi: 10.4137/CMAMD.S39160. Epub 2016 Jul 7
[PubMed PMID: 27429562]
Level 1 (high-level) evidence
[7]
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop Dj, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006:8(4):315-7
[PubMed PMID: 16923606]
[8]
Vora A, Borg-Stein J, Nguyen RT. Regenerative injection therapy for osteoarthritis: fundamental concepts and evidence-based review. PM & R : the journal of injury, function, and rehabilitation. 2012 May:4(5 Suppl):S104-9. doi: 10.1016/j.pmrj.2012.02.005. Epub
[PubMed PMID: 22632688]
[9]
Dragoo JL, Braun HJ, Durham JL, Ridley BA, Odegaard JI, Luong R, Arnoczky SP. Comparison of the acute inflammatory response of two commercial platelet-rich plasma systems in healthy rabbit tendons. The American journal of sports medicine. 2012 Jun:40(6):1274-81. doi: 10.1177/0363546512442334. Epub 2012 Apr 10
[PubMed PMID: 22495144]
[10]
Fitzpatrick J, Bulsara M, Zheng MH. The Effectiveness of Platelet-Rich Plasma in the Treatment of Tendinopathy: A Meta-analysis of Randomized Controlled Clinical Trials. The American journal of sports medicine. 2017 Jan:45(1):226-233. doi: 10.1177/0363546516643716. Epub 2016 Jul 21
[PubMed PMID: 27268111]
Level 1 (high-level) evidence
[11]
Braun HJ, Kim HJ, Chu CR, Dragoo JL. The effect of platelet-rich plasma formulations and blood products on human synoviocytes: implications for intra-articular injury and therapy. The American journal of sports medicine. 2014 May:42(5):1204-10. doi: 10.1177/0363546514525593. Epub 2014 Mar 14
[PubMed PMID: 24634448]
[13]
Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, Maguire PB. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood. 2004 Mar 15:103(6):2096-104
[PubMed PMID: 14630798]
[14]
El-Sharkawy H, Kantarci A, Deady J, Hasturk H, Liu H, Alshahat M, Van Dyke TE. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. Journal of periodontology. 2007 Apr:78(4):661-9
[PubMed PMID: 17397313]
[15]
Veronesi F, Giavaresi G, Tschon M, Borsari V, Nicoli Aldini N, Fini M. Clinical use of bone marrow, bone marrow concentrate, and expanded bone marrow mesenchymal stem cells in cartilage disease. Stem cells and development. 2013 Jan 15:22(2):181-92. doi: 10.1089/scd.2012.0373. Epub 2012 Nov 16
[PubMed PMID: 23030230]
[16]
Medical Advisory Secretariat. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis. Ontario health technology assessment series. 2005:5(10):1-66
[PubMed PMID: 23074461]
[17]
Axe JM, Snyder-Mackler L, Axe MJ. The role of viscosupplementation. Sports medicine and arthroscopy review. 2013 Mar:21(1):18-22. doi: 10.1097/JSA.0b013e3182673241. Epub
[PubMed PMID: 23314264]
[18]
Chahla J, Mannava S, Cinque ME, Geeslin AG, Codina D, LaPrade RF. Bone Marrow Aspirate Concentrate Harvesting and Processing Technique. Arthroscopy techniques. 2017 Apr:6(2):e441-e445. doi: 10.1016/j.eats.2016.10.024. Epub 2017 Apr 10
[PubMed PMID: 28580265]
[19]
Jain NK, Gulati M. Platelet-rich plasma: a healing virtuoso. Blood research. 2016 Mar:51(1):3-5. doi: 10.5045/br.2016.51.1.3. Epub 2016 Mar 25
[PubMed PMID: 27104183]
[20]
Dechow E, Davies RK, Carr AJ, Thompson PW. A randomized, double-blind, placebo-controlled trial of sclerosing injections in patients with chronic low back pain. Rheumatology (Oxford, England). 1999 Dec:38(12):1255-9
[PubMed PMID: 10587555]
Level 1 (high-level) evidence
[21]
Buchanan BK, DeLuca JP, Lammlein KP. Technical Innovation Case Report: Ultrasound-Guided Prolotherapy Injection for Insertional Achilles Calcific Tendinosis. Case reports in orthopedics. 2016:2016():1560161
[PubMed PMID: 27974984]
Level 3 (low-level) evidence
[22]
Vangsness CT Jr, Farr J 2nd, Boyd J, Dellaero DT, Mills CR, LeRoux-Williams M. Adult human mesenchymal stem cells delivered via intra-articular injection to the knee following partial medial meniscectomy: a randomized, double-blind, controlled study. The Journal of bone and joint surgery. American volume. 2014 Jan 15:96(2):90-8. doi: 10.2106/JBJS.M.00058. Epub
[PubMed PMID: 24430407]
Level 1 (high-level) evidence
[23]
Poulos J. The limited application of stem cells in medicine: a review. Stem cell research & therapy. 2018 Jan 2:9(1):1. doi: 10.1186/s13287-017-0735-7. Epub 2018 Jan 2
[PubMed PMID: 29291747]
[24]
Zehnder JL, Leung LL. Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin. Blood. 1990 Nov 15:76(10):2011-6
[PubMed PMID: 2242423]
[25]
Landesberg R, Burke A, Pinsky D, Katz R, Vo J, Eisig SB, Lu HH. Activation of platelet-rich plasma using thrombin receptor agonist peptide. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons. 2005 Apr:63(4):529-35
[PubMed PMID: 15789326]
[26]
HUNT WE, BAIRD WC. Complications following injection of sclerosing agent to precipitate fibro-osseous proliferation. Journal of neurosurgery. 1961 Jul:18():461-5
[PubMed PMID: 13716870]
[27]
SCHNEIDER RC, WILLIAMS JJ, LISS L. Fatality after injection of sclerosing agent to precipitate fibro-osseous proliferation. Journal of the American Medical Association. 1959 Aug 8:170(15):1768-72
[PubMed PMID: 13672766]
[28]
Richette P, Chevalier X, Ea HK, Eymard F, Henrotin Y, Ornetti P, Sellam J, Cucherat M, Marty M. Hyaluronan for knee osteoarthritis: an updated meta-analysis of trials with low risk of bias. RMD open. 2015:1(1):e000071. doi: 10.1136/rmdopen-2015-000071. Epub 2015 May 14
[PubMed PMID: 26509069]
Level 1 (high-level) evidence
[29]
Yu FF, Xia CT, Fang H, Han J, Younus MI, Guo X. Evaluation of the therapeutic effect of treatment with intra-articular hyaluronic acid in knees for Kashin-Beck disease: a meta-analysis. Osteoarthritis and cartilage. 2014 Jun:22(6):718-25. doi: 10.1016/j.joca.2014.04.012. Epub 2014 Apr 30
[PubMed PMID: 24792210]
Level 1 (high-level) evidence
[30]
Miller LE, Block JE. US-Approved Intra-Articular Hyaluronic Acid Injections are Safe and Effective in Patients with Knee Osteoarthritis: Systematic Review and Meta-Analysis of Randomized, Saline-Controlled Trials. Clinical medicine insights. Arthritis and musculoskeletal disorders. 2013:6():57-63. doi: 10.4137/CMAMD.S12743. Epub 2013 Sep 1
[PubMed PMID: 24027421]
Level 1 (high-level) evidence
[31]
Miller LE, Bhattacharyya S, Parrish WR, Fredericson M, Bisson B, Altman RD. Safety of Intra-Articular Hyaluronic Acid for Knee Osteoarthritis: Systematic Review and Meta-Analysis of Randomized Trials Involving More than 8,000 Patients. Cartilage. 2021 Dec:13(1_suppl):351S-363S. doi: 10.1177/1947603519888783. Epub 2019 Nov 16
[PubMed PMID: 31735075]
Level 1 (high-level) evidence
[32]
Campbell KA, Erickson BJ, Saltzman BM, Mascarenhas R, Bach BR Jr, Cole BJ, Verma NN. Is Local Viscosupplementation Injection Clinically Superior to Other Therapies in the Treatment of Osteoarthritis of the Knee: A Systematic Review of Overlapping Meta-analyses. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 2015 Oct:31(10):2036-45.e14. doi: 10.1016/j.arthro.2015.03.030. Epub 2015 May 19
[PubMed PMID: 25998016]
Level 1 (high-level) evidence
[33]
Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T. Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. The American journal of sports medicine. 2010 Feb:38(2):255-62. doi: 10.1177/0363546509355445. Epub
[PubMed PMID: 20448192]
Level 1 (high-level) evidence
[34]
Gosens T, Peerbooms JC, van Laar W, den Oudsten BL. Ongoing positive effect of platelet-rich plasma versus corticosteroid injection in lateral epicondylitis: a double-blind randomized controlled trial with 2-year follow-up. The American journal of sports medicine. 2011 Jun:39(6):1200-8. doi: 10.1177/0363546510397173. Epub 2011 Mar 21
[PubMed PMID: 21422467]
Level 1 (high-level) evidence
[35]
Krogh TP, Fredberg U, Stengaard-Pedersen K, Christensen R, Jensen P, Ellingsen T. Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial. The American journal of sports medicine. 2013 Mar:41(3):625-35. doi: 10.1177/0363546512472975. Epub 2013 Jan 17
[PubMed PMID: 23328738]
Level 1 (high-level) evidence
[36]
Sundman EA, Cole BJ, Karas V, Della Valle C, Tetreault MW, Mohammed HO, Fortier LA. The anti-inflammatory and matrix restorative mechanisms of platelet-rich plasma in osteoarthritis. The American journal of sports medicine. 2014 Jan:42(1):35-41. doi: 10.1177/0363546513507766. Epub 2013 Nov 5
[PubMed PMID: 24192391]
[37]
Riboh JC, Saltzman BM, Yanke AB, Fortier L, Cole BJ. Effect of Leukocyte Concentration on the Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis. The American journal of sports medicine. 2016 Mar:44(3):792-800. doi: 10.1177/0363546515580787. Epub 2015 Apr 29
[PubMed PMID: 25925602]
[38]
Orrego M, Larrain C, Rosales J, Valenzuela L, Matas J, Durruty J, Sudy H, Mardones R. Effects of platelet concentrate and a bone plug on the healing of hamstring tendons in a bone tunnel. Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association. 2008 Dec:24(12):1373-80. doi: 10.1016/j.arthro.2008.07.016. Epub 2008 Sep 30
[PubMed PMID: 19038708]
[39]
Podesta L, Crow SA, Volkmer D, Bert T, Yocum LA. Treatment of partial ulnar collateral ligament tears in the elbow with platelet-rich plasma. The American journal of sports medicine. 2013 Jul:41(7):1689-94. doi: 10.1177/0363546513487979. Epub 2013 May 10
[PubMed PMID: 23666850]
[40]
Dines JS, Williams PN, ElAttrache N, Conte S, Tomczyk T, Osbahr DC, Dines DM, Bradley J, Ahmad CS. Platelet-Rich Plasma Can Be Used to Successfully Treat Elbow Ulnar Collateral Ligament Insufficiency in High-Level Throwers. American journal of orthopedics (Belle Mead, N.J.). 2016 Jul-Aug:45(5):296-300
[PubMed PMID: 27552453]
[41]
Pirvu TN, Schroeder JE, Peroglio M, Verrier S, Kaplan L, Richards RG, Alini M, Grad S. Platelet-rich plasma induces annulus fibrosus cell proliferation and matrix production. European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society. 2014 Apr:23(4):745-53. doi: 10.1007/s00586-014-3198-x. Epub 2014 Jan 28
[PubMed PMID: 24469887]
[42]
Akeda K, An HS, Pichika R, Attawia M, Thonar EJ, Lenz ME, Uchida A, Masuda K. Platelet-rich plasma (PRP) stimulates the extracellular matrix metabolism of porcine nucleus pulposus and anulus fibrosus cells cultured in alginate beads. Spine. 2006 Apr 20:31(9):959-66
[PubMed PMID: 16641770]
[43]
Kim HJ, Yeom JS, Koh YG, Yeo JE, Kang KT, Kang YM, Chang BS, Lee CK. Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-α and IL-1. Journal of orthopaedic research : official publication of the Orthopaedic Research Society. 2014 Apr:32(4):551-6. doi: 10.1002/jor.22532. Epub 2013 Dec 11
[PubMed PMID: 24338609]
[44]
Levi D, Horn S, Tyszko S, Levin J, Hecht-Leavitt C, Walko E. Intradiscal Platelet-Rich Plasma Injection for Chronic Discogenic Low Back Pain: Preliminary Results from a Prospective Trial. Pain medicine (Malden, Mass.). 2016 Jun:17(6):1010-22. doi: 10.1093/pm/pnv053. Epub 2015 Dec 26
[PubMed PMID: 26814283]
[45]
Tuakli-Wosornu YA, Terry A, Boachie-Adjei K, Harrison JR, Gribbin CK, LaSalle EE, Nguyen JT, Solomon JL, Lutz GE. Lumbar Intradiskal Platelet-Rich Plasma (PRP) Injections: A Prospective, Double-Blind, Randomized Controlled Study. PM & R : the journal of injury, function, and rehabilitation. 2016 Jan:8(1):1-10; quiz 10. doi: 10.1016/j.pmrj.2015.08.010. Epub 2015 Aug 24
[PubMed PMID: 26314234]
Level 1 (high-level) evidence
[46]
Monfett M, Harrison J, Boachie-Adjei K, Lutz G. Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update. International orthopaedics. 2016 Jun:40(6):1321-8. doi: 10.1007/s00264-016-3178-3. Epub 2016 Apr 12
[PubMed PMID: 27073034]
[47]
Wu J, Du Z, Lv Y, Zhang J, Xiong W, Wang R, Liu R, Zhang G, Liu Q. A New Technique for the Treatment of Lumbar Facet Joint Syndrome Using Intra-articular Injection with Autologous Platelet Rich Plasma. Pain physician. 2016 Nov-Dec:19(8):617-625
[PubMed PMID: 27906940]
[48]
Wu J, Zhou J, Liu C, Zhang J, Xiong W, Lv Y, Liu R, Wang R, Du Z, Zhang G, Liu Q. A Prospective Study Comparing Platelet-Rich Plasma and Local Anesthetic (LA)/Corticosteroid in Intra-Articular Injection for the Treatment of Lumbar Facet Joint Syndrome. Pain practice : the official journal of World Institute of Pain. 2017 Sep:17(7):914-924. doi: 10.1111/papr.12544. Epub 2017 Feb 22
[PubMed PMID: 27989008]
[49]
Manchikanti L, Centeno CJ, Atluri S, Albers SL, Shapiro S, Malanga GA, Abd-Elsayed A, Jerome M, Hirsch JA, Kaye AD, Aydin SM, Beall D, Buford D, Borg-Stein J, Buenaventura RM, Cabaret JA, Calodney AK, Candido KD, Cartier C, Latchaw R, Diwan S, Dodson E, Fausel Z, Fredericson M, Gharibo CG, Gupta M, Kaye AM, Knezevic NN, Kosanovic R, Lucas M, Manchikanti MV, Mason RA, Mautner K, Murala S, Navani A, Pampati V, Pastoriza S, Pasupuleti R, Philip C, Sanapati MR, Sand T, Shah RV, Soin A, Stemper I, Wargo BW, Hernigou P. Bone Marrow Concentrate (BMC) Therapy in Musculoskeletal Disorders: Evidence-Based Policy Position Statement of American Society of Interventional Pain Physicians (ASIPP). Pain physician. 2020 Mar:23(2):E85-E131
[PubMed PMID: 32214287]